EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting CDR status over 36 months with a recall‐based digital cognitive biomarker

Davide Bruno iD, Ainara Jauregi-Zinkunegi iD, Jason R Bock iD, Alzheimer's Disease Neuroimaging Initiative

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Davide Bruno und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Liverpool John Moores University, Liverpool, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Mental Recall, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Embic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Word‐list recall tests are routinely used for cognitive assessment, and process scoring may improve their accuracy. We examined whether Alzheimer's Disease Assessment Scale–Cognitive subscale (ADAS‐Cog) derived, process‐based digital cognitive biomarkers (DCBs) at baseline predicted Clinical Dementia Rating (CDR) longitudinally and compared them to standard metrics. METHODS Analyses were performed with Alzheimer's Disease Neuroimaging Initiative (ADNI) data from 330 participants (mean age = 71.4 ± 7.2). We conducted regression analyses predicting CDR at 36 months, controlling for demographics and genetic risk, with ADAS‐Cog traditional scores and DCBs as predictors. RESULTS The best predictor of CDR at 36 months was M , a DCB reflecting recall ability (area under the curve = 0.84), outperforming traditional scores. Diagnostic results suggest that M may be particularly useful to identify individuals who are unlikely to decline. DISCUSSION These results suggest that M outperforms ADAS‐Cog traditional metrics and supports process scoring for word‐list recall tests. More research is needed to determine further applicability with other tests and populations. Highlights Process scoring and latent modeling were more effective than traditional scoring. Latent recall ability ( M ) was the best predictor of Clinical Dementia Rating decline at 36 months. The top digital cognitive biomarker model had odds ≈ 90 times greater than the top Alzheimer's Disease Assessment Scale–Cognitive subscale model. Particularly high negative predictive value supports literature on cognitive testing as a useful screen. Consideration of both cognitive and pathological outcomes is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMental RecallBiomarkersHumansMaleFemaleAgedNeuropsychological TestsLongitudinal StudiesMental Status and Dementia TestsPredictive Value of TestsCognitive DysfunctionAged, 80 and overDisease Progression

Stichwörter der Autor:innen

Alzheimer's Disease Assessment Scale–Cognitive subscaleClinical Dementia Ratingcognitive assessmentdigital cognitive biomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Psychology, Liverpool John Moores University, Liverpool, UK.
  • Embic Corporation, Newport Beach, California, USA.

ORCID-Profile: Davide Bruno, Ainara Jauregi-Zinkunegi, Jason R Bock

Förderung

  • NIA NIH HHS
  • Embic

Zitieren

APA

Bruno, D., Jauregi-Zinkunegi, A., Bock, J. R., & Alzheimer's Disease Neuroimaging Initiative (2024). Predicting CDR status over 36 months with a recall‐based digital cognitive biomarker. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14213

Vancouver

Bruno D, Jauregi-Zinkunegi A, Bock JR, Alzheimer's Disease Neuroimaging Initiative. Predicting CDR status over 36 months with a recall‐based digital cognitive biomarker. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14213

BibTeX
@article{Bruno2024,
  author = {Bruno, Davide and Jauregi-Zinkunegi, Ainara and Bock, Jason R and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
  title = {Predicting CDR status over 36 months with a recall‐based digital cognitive biomarker},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14213}
}
Kostenlos starten →